Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ferroptosis: a new promising target for hepatocellular carcinoma therapy
Qiaoping Xu, Lanqi Ren, Ning Ren, et al.
Molecular and Cellular Biochemistry (2023) Vol. 479, Iss. 10, pp. 2615-2636
Closed Access | Times Cited: 12

Showing 12 citing articles:

Pharmacological therapy of metabolic dysfunction-associated steatotic liver disease-driven hepatocellular carcinoma
Yumin Wang, Joshua S. Fleishman, Tongda Li, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 11
Emerging trends of phytochemicals as ferroptosis modulators in cancer therapy
Fahad Khan, Pratibha Pandey, Meenakshi Verma, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116363-116363
Open Access | Times Cited: 5
A Dual‐Targeting Biomimetic Nanoplatform Integrates SDT/CDT/Gas Therapy to Boost Synergistic Ferroptosis for Orthotopic Hepatocellular Carcinoma Therapy
Wen Meng, Ting Chen, Xueping Li, et al.
Advanced Science (2025)
Open Access
CD155 promotes the advancement of hepatocellular carcinoma by suppressing the p53-mediated ferroptosis via interacting with CD96
Zhenhui Lu, Jingzhe Yu, Tuoyu Lu, et al.
Journal of Molecular Medicine (2025)
Closed Access
Investigating autophagy and intricate cellular mechanisms in hepatocellular carcinoma: Emphasis on cell death mechanism crosstalk
Gang Wang, Xiaodi Jiang, Pedram Torabian, et al.
Cancer Letters (2024) Vol. 588, pp. 216744-216744
Open Access | Times Cited: 4
Pharmacologically inducing anoikis offers novel therapeutic opportunities in hepatocellular carcinoma
Yumin Wang, Joshua S Fleishman, Jinhua Wang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116878-116878
Open Access | Times Cited: 4
Semaglutide restores astrocyte–vascular interactions and blood–brain barrier integrity in a model of diet-induced metabolic syndrome
Vanessa Estato, Nathalie Obadia, Paulo Henrique Petrone Chateaubriand, et al.
Diabetology & Metabolic Syndrome (2025) Vol. 17, Iss. 1
Open Access
GINS4 silencing mediates hepatocellular cancer cell proliferation, cycle and ferroptosis through POLE2
Jiarui Yao, Huaicheng Yang, Meng Yuan, et al.
Cellular Signalling (2025) Vol. 131, pp. 111742-111742
Closed Access
The multifaceted perspectives on the regulation of lncRNAs in hepatocellular carcinoma ferroptosis: from bench-to-bedside
Xin Jin, C. Huang, Yue Tian
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Integrated multiomics analysis identified comprehensive crosstalk between diverse programmed cell death patterns and novel molecular subtypes in Hepatocellular Carcinoma
Li Chen, Yuanbo Hu, Yu Li, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Pharmacologically Targeting Ferroptosis and Cuproptosis in Neuroblastoma
Ying Liu, Joshua S Fleishman, Hongquan Wang, et al.
Molecular Neurobiology (2024)
Open Access
[Ferroptosis inducer Erastin inhibits proliferation of liver cancer cells
Pan Zhao, Zihui Zhou, Liang Yu, et al.
PubMed (2024) Vol. 44, Iss. 11, pp. 2131-2136
Closed Access
Page 1

Scroll to top